Table 2.
Results of home-based devices of T2DM indicators at baseline and after three months.
| Clinical characteristics (mean ± SD) | N | Baseline | N | 3 months | N with both measures | Difference (95% CI) (3 months–baseline) | p value |
|---|---|---|---|---|---|---|---|
| Blood glucose (mg/dL) | |||||||
| FBG | 26 | 192.2 (61.4) | 31 | 147.9 (40.3) | 20 | −40.1 (−70.8–−9.3) | 0.013 |
| RBG | 32 | 199.5 (66.4) | 25 | 171.3 (83.3) | 21 | −40.8 (−84.7–3.2) | 0.067 |
| Blood pressure (mmHg) | |||||||
| SBP | 37 | 135.4 (15.3) | 38 | 133.5 (15.1) | 37 | −2.2 (−7.2–2.8) | 0.386 |
| DBP | 37 | 85.7 (11.7) | 38 | 82.5 (9.4) | 37 | −3.5 (−6.6–−0.4) | 0.028 |
| Pulse rate (beats/min) | 37 | 82.7 (12.5) | 38 | 82.2 (15.4) | 37 | −0.7 (−4.5–3.1) | 0.710 |
| Oxygen saturation (%) | 38 | 97.4 (1.4) | 38 | 95.7 (12.7) | 38 | −1.8 (−5.9–2.4) | 0.393 |
FBG: fasting blood glucose; RBG: random blood glucose; SBP: systolic blood pressure; DBP: diastolic blood pressure; CI: confidence interval.